Infectious Disease Diagnostics - Global Market Outlook (2018-2027)

   |      |      |  

Infectious Disease Diagnostics - Global Market Outlook (2018-2027)

"The Global Infectious Disease Diagnostics Market is accounted for $15.53 billion in 2018 and is expected to reach $28.79 billion by 2027 growing at a CAGR of 7.1% during the forecast period. Increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of infectious diseases are the major factors propelling the market growth. However, lack of skilled technicians/professionals and high cost of these devices is hampering the market growth.

Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Any bacteria which cause infectious disease are called pathogens. Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.

Based on the technology, DNA sequencing & next-generation sequencing (NGS) segment is going to have a lucrative growth during the forecast period due to factors such as development in sequencing technologies, rising awareness and taking of personalized medicine in which this technology has major applications and growing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing are expected to boost the growth of this technology in the future. By geography, North America is likely to have a huge demand owing to extremely developed healthcare system, mounting prevalence of infectious diseases, the existence of a huge number of leading national clinical laboratories, and simple accessibility to technologically advanced devices in the region.

Some of the key players profiled in the Infectious Disease Diagnostics Market are Abbott Diagnostic, Alere, Beckman Coulter , Becton, Dickinson and Company (BD), bioMu00e9rieux, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diasorin, Diaxonhit , Eiken Chemical, EMD Millipore, J.Mitra, Meridian Bioscience, Roche Diagnostic , Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific and Trinity Biotech.

Product & Services Covered:
• Assays, Kits, & Reagents
• Instruments
• Software

Test Types Covered:
• Biopsies
• Imaging Test
• Laboratory Tests

Technologies Covered:
• Biochemical Characterization
• Clinical Microbiology
• Conventional Techniques
• DNA Microarray
• DNA Sequencing & Next-Generation Sequencing (NGS)
• Hybridization and Microarrays
• Immunodiagnostics
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Microscopy
• Molecular Techniques
• POC infectious disease diagnostics test
• Polymerase Chain Reaction (PCR)

Disease Types Covered:
• Acquired Immunodeficiency Syndrome (AIDS)
• Bacterial Infection
• Cardiovascular infection
• Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
• Coronavirus
• Glandular fever
• Hepatitis
• Hospital-Acquired Infections (HAIS)
• Human Immunodeficiency Virus (HIV)
• Human Papillomavirus (HPV)
• Influenza
• Methicillin-resistant Staphylococcus Aureus (MRSA)
• Tuberculosis (TB)
• Other Disease Types

End Users Covered:
• Academic/Research Institutes
• Ambulatory Surgical Centers
• Blood Banks
• Contract Research Organization
• Diagnostic Clinics
• Home healthcare
• Hospital/Clinical Laboratories
• Nursing Homes
• Physician Offices
• Reference Laboratories
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product & Service
5.1 Introduction
5.2 Assays, Kits, & Reagents
5.3 Instruments
5.4 Software

6 Global Infectious Disease Diagnostics Market, By Test Type
6.1 Introduction
6.2 Biopsies
6.3 Imaging Test
6.4 Laboratory Tests

7 Global Infectious Disease Diagnostics Market, By Technology
7.1 Introduction
7.2 Biochemical Characterization
7.3 Clinical Microbiology
7.4 Conventional Techniques
7.5 DNA Microarray
7.6 DNA Sequencing & Next-Generation Sequencing (NGS)
7.7 Hybridization and Microarrays
7.8 Immunodiagnostics
7.9 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.10 Microscopy
7.11 Molecular Techniques
7.12 POC infectious disease diagnostics test
7.13 Polymerase Chain Reaction (PCR)

8 Global Infectious Disease Diagnostics Market, By Disease Type
8.1 Introduction
8.2 Acquired Immunodeficiency Syndrome (AIDS)
8.3 Bacterial Infection
8.4 Cardiovascular infection
8.5 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT\/NG)
8.6 Coronavirus
8.7 Glandular fever
8.8 Hepatitis
8.9 Hospital-Acquired Infections (HAIS)
8.10 Human Immunodeficiency Virus (HIV)
8.11 Human Papillomavirus (HPV)
8.12 Influenza
8.13 Methicillin-resistant Staphylococcus Aureus (MRSA)
8.14 Tuberculosis (TB)
8.15 Other Disease Types

9 Global Infectious Disease Diagnostics Market, By End User
9.1 Introduction
9.2 Academic\/Research Institutes
9.3 Ambulatory Surgical Centers
9.4 Blood Banks
9.5 Contract Research Organization
9.6 Diagnostic Clinics
9.7 Home healthcare
9.8 Hospital\/Clinical Laboratories
9.9 Nursing Homes
9.10 Physician Offices
9.11 Reference Laboratories

10 Global Infectious Disease Diagnostics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Abbott Diagnostic
12.2 Alere
12.3 Beckman Coulter
12.4 Becton, Dickinson and Company (BD)
12.5 bioM\u00e9rieux
12.6 Bio-Rad Laboratories
12.7 Cavidi
12.8 Cepheid
12.9 Corgenix
12.10 Diasorin
12.11 Diaxonhit
12.12 Eiken Chemical
12.13 EMD Millipore
12.14 J.Mitra
12.15 Meridian Bioscience
12.16 Roche Diagnostic
12.17 Siemens Healthcare Diagnostics
12.18 TECHLAB
12.19 Thermo Fisher Scientific
12.20 Trinity Biotech

List of Tables
Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product & Service (2017-2027) ($MN)
Table 3 Global Infectious Disease Diagnostics Market Outlook, By Assays, Kits, & Reagents (2017-2027) ($MN)
Table 4 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
Table 5 Global Infectious Disease Diagnostics Market Outlook, By Software (2017-2027) ($MN)
Table 6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
Table 7 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2017-2027) ($MN)
Table 8 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2017-2027) ($MN)
Table 9 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2017-2027) ($MN)
Table 10 Global Infectious Disease Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
Table 11 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2017-2027) ($MN)
Table 12 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2017-2027) ($MN)
Table 13 Global Infectious Disease Diagnostics Market Outlook, By Conventional Techniques (2017-2027) ($MN)
Table 14 Global Infectious Disease Diagnostics Market Outlook, By DNA Microarray (2017-2027) ($MN)
Table 15 Global Infectious Disease Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2017-2027) ($MN)
Table 16 Global Infectious Disease Diagnostics Market Outlook, By Hybridization and Microarrays (2017-2027) ($MN)
Table 17 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2017-2027) ($MN)
Table 18 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
Table 19 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2017-2027) ($MN)
Table 20 Global Infectious Disease Diagnostics Market Outlook, By Molecular Techniques (2017-2027) ($MN)
Table 21 Global Infectious Disease Diagnostics Market Outlook, By POC infectious disease diagnostics test (2017-2027) ($MN)
Table 22 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
Table 23 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2017-2027) ($MN)
Table 24 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2017-2027) ($MN)
Table 25 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (2017-2027) ($MN)
Table 26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular infection (2017-2027) ($MN)
Table 27 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT\/NG) (2017-2027) ($MN)
Table 28 Global Infectious Disease Diagnostics Market Outlook, By Coronavirus (2017-2027) ($MN)
Table 29 Global Infectious Disease Diagnostics Market Outlook, By Glandular fever (2017-2027) ($MN)
Table 30 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis (2017-2027) ($MN)
Table 31 Global Infectious Disease Diagnostics Market Outlook, By Hospital-Acquired Infections (HAIS) (2017-2027) ($MN)
Table 32 Global Infectious Disease Diagnostics Market Outlook, By Human Immunodeficiency Virus (HIV) (2017-2027) ($MN)
Table 33 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2017-2027) ($MN)
Table 34 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2017-2027) ($MN)
Table 35 Global Infectious Disease Diagnostics Market Outlook, By Methicillin-resistant Staphylococcus Aureus (MRSA) (2017-2027) ($MN)
Table 36 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (TB) (2017-2027) ($MN)
Table 37 Global Infectious Disease Diagnostics Market Outlook, By Other Disease Types (2017-2027) ($MN)
Table 38 Global Infectious Disease Diagnostics Market Outlook, By End User (2017-2027) ($MN)
Table 39 Global Infectious Disease Diagnostics Market Outlook, By Academic\/Research Institutes (2017-2027) ($MN)
Table 40 Global Infectious Disease Diagnostics Market Outlook, By Ambulatory Surgical Centers (2017-2027) ($MN)
Table 41 Global Infectious Disease Diagnostics Market Outlook, By Blood Banks (2017-2027) ($MN)
Table 42 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2017-2027) ($MN)
Table 43 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Clinics (2017-2027) ($MN)
Table 44 Global Infectious Disease Diagnostics Market Outlook, By Home healthcare (2017-2027) ($MN)
Table 45 Global Infectious Disease Diagnostics Market Outlook, By Hospital\/Clinical Laboratories (2017-2027) ($MN)
Table 46 Global Infectious Disease Diagnostics Market Outlook, By Nursing Homes (2017-2027) ($MN)
Table 47 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2017-2027) ($MN)
Table 48 Global Infectious Disease Diagnostics Market Outlook, By Reference Laboratories (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
"

Infectious Disease Diagnostics - Global Market Outlook (2018-2027)

.